Corcept Therapeutics
CORT
#2093
Rank
HK$59.30 B
Marketcap
HK$566.07
Share price
-1.21%
Change (1 day)
195.94%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of February 2025 (TTM): 12.1

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.9. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.31-64.42%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
4.19-65.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
18.7 54.35%๐Ÿ‡บ๐Ÿ‡ธ USA
2.41-80.06%๐Ÿ‡บ๐Ÿ‡ธ USA
3.31-72.68%๐Ÿ‡บ๐Ÿ‡ธ USA
1.25-89.65%๐Ÿ‡บ๐Ÿ‡ธ USA
5.55-54.18%๐Ÿ‡บ๐Ÿ‡ธ USA
4.46-63.15%๐Ÿ‡บ๐Ÿ‡ธ USA